The role of inflammation in CNS injury and disease
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
For many years, the central nervous system (CNS) was considered to be ‘immune privileged’, neither susceptible to nor contributing to inflammation. It is now appreciated that the CNS does exhibit features of inflammation, and in response to injury, infection or disease, resident CNS cells generate inflammatory mediators, including proinflammatory cytokines, prostaglandins, free radicals and complement, which in turn induce chemokines and adhesion molecules, recruit immune cells, and activate glial cells. Much of the key evidence demonstrating that inflammation and inflammatory mediators contribute to acute, chronic and psychiatric CNS disorders is summarised in this review. However, inflammatory mediators may have dual roles, with detrimental acute effects but beneficial effects in long‐term repair and recovery, leading to complications in their application as novel therapies. These may be avoided in acute diseases in which treatment administration might be relatively short‐term. Targeting interleukin (IL)‐1 is a promising novel therapy for stroke and traumatic brain injury, the naturally occurring antagonist (IL‐1ra) being well tolerated by rheumatoid arthritis patients. Chronic disorders represent a greater therapeutic challenge, a problem highlighted in Alzheimer's disease (AD); significant data suggested that anti‐inflammatory agents might reduce the probability of developing AD, or slow its progression, but prospective clinical trials of nonsteroidal anti‐inflammatory drugs or cyclooxygenase inhibitors have been disappointing. The complex interplay between inflammatory mediators, ageing, genetic background, and environmental factors may ultimately regulate the outcome of acute CNS injury and progression of chronic neurodegeneration, and be critical for development of effective therapies for CNS diseases. British Journal of Pharmacology (2006) 147, S232–S240. doi:10.1038/sj.bjp.0706400
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As various neurological and psychiatric diseases have been associated with neuroinflammation in some post-mortem studies,183, 184, 185”
From Markers of microglia in post-mortem brain samples from patients with Alzheimer’s disease: a systematic review (2018) · cites this paper as [183]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Stroke is caused by ischaemia, leading to inflammation [900] and to the formation of ROS and other damaging free radicals [901] in the brain”
The cited source says what the claim attributes to it.
In the citing paper
“These processes induce adhesion molecules and, in order, mobilize immune and glial cells in a parallel and synergistic way (94, 126 -128).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [127]
In the citing paper
“Thus, although this is not the focus of the present more physiologically based review, we recognise that many of relationships between ROSs and oxidative stress and overt progressive diseases may be mediated via the inflammatory signalling pathways involved in 'innate immunity' [900,1991-1993].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PLEIOTROPIC EFFECTS OF STATINS
Liao, J. K., & Laufs, U. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095748 · Cited by 1,994
Reactive Astrocytes Protect Tissue and Preserve Function after Spinal Cord Injury
Faulkner, J. R., Herrmann, J. E., Woo, M. J., Tansey, K. E., Doan, N. B., & Sofroniew, M. V. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3547-03.2004 · Cited by 1,598 · cited 1×
“…for repair and recovery, but in fact this increases neuronal loss from the injury site and inhibits repair of the BBB and axonal remyelination (Faulkner et al., 2004), partly because astrocytes produce neurotrophic factors such as nerve growth factor and brain-derived growth factor that are…”
BackgroundMcGeer, P. L., Schulzer, M., & McGeer, E. G. (1996) · Neurology · doi:10.1212/wnl.47.2.425 · Cited by 1,367 · cited 1×
“Although other epidemiological studies also suggest a beneficial role for antiinflammatory agents in AD (McGeer et al., 1996), the general view from prospective trials of nonsteroidal inflammatory drugs (NSAIDs) is that they are disappointingly variable.”
BackgroundTNF neutralization in MS: Results of a randomized, placebo-controlled multicenter study
The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group (1999) · Neurology · doi:10.1212/wnl.53.3.457 · Cited by 1,017
Interleukin 1 in the brain: biology, pathology and therapeutic target
Rothwell, N. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01661-1 · Cited by 671 · cited 3×
“IL-1 was discovered as an important endogenous pyrogen, and is now recognised as the ‘prototypic inflammatory cytokine’ (reviewed by Rothwell & Luheshi, 2000).”
BackgroundInfluentialSelf-citationPerry, V. H. (2004) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2004.01.004 · Cited by 560 · cited 2×
“…metalloproteinase and iNOS activities, and breakdown of the BBB. Complications of its use however include inhibition of remyelination in MS models, and observations that microglial activation may be associated with anti-inflammatory cytokine expression rather than proinflammatory (Perry, 2004).”
BackgroundInflammation and the Degenerative Diseases of Aging
McGEER, P. L., & McGEER, E. G. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1332.007 · Cited by 518 · cited 1×
“The complement cascade is activated, and mRNAs for complement proteins are upregulated in PD (and AD) to a greater extent than in peripheral inflammatory diseases such as rheumatoid arthritis (reviewed by McGeer & McGeer, 2004).”
BackgroundScherbel, U., Raghupathi, R., Nakamura, M., Saatman, K. E., Trojanowski, J. Q., Neugebauer, E., Marino, M. W., & McIntosh, T. K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8721 · Cited by 415 · cited 1×
“…injury, the TNFa knockout mice show less behavioural impairment than the wild-type controls, but while the wild-type mice recovered in the weeks following injury, the knockout mice did not, remaining significantly impaired both in terms of histological damage and behaviour (Scherbel et al., 1999).”
BackgroundNew Insights into the Biology of the Acute Phase Response
Suffredini, A. F., Fantuzzi, G., Badolato, R., Oppenheim, J. J., & O'Grady, N. P. (1999) · Journal of Clinical Immunology · doi:10.1023/a:1020563913045 · Cited by 391 · cited 1×
“This represents another host defence mechanism which can limit proliferation of invading pathogens (Suffredini et al., 1999).”
BackgroundVezzani, A., Moneta, D., Richichi, C., Aliprandi, M., Burrows, S. J., Ravizza, T., Perego, C., & De Simoni, M. G. (2002) · Epilepsia · doi:10.1046/j.1528-1157.43.s.5.14.x · Cited by 386 · cited 1×
“Exogenous IL-1b enhances chemically induced seizures in rats and IL-1ra inhibits motor seizures and delays their onset (see Vezzani et al., 2002).”
Background
Cited by
Items 301–400 of 1,000
Risbrough, V. B., Vaughn, M. N., & Friend, S. F. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.11.012 · Cited by 83
Moreira, M. S., Velasco, I. T., Ferreira, L. S., Ariga, S. K. K., Barbeiro, D. F., Meneguzzo, D. T., Abatepaulo, F., & Marques, M. M. (2009) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2009.09.002 · Cited by 84
Neuroprotection by IFN-γ via astrocyte-secreted IL-6 in acute neuroinflammation
Sun, L., Li, Y., Jia, X., Wang, Q., Li, Y., Hu, M., Tian, L., Yang, J., Xing, W., Zhang, W., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16990 · Cited by 72
“CNS inflammation is often initiated peripherally, i.e. via severe bacterial or viral infections.”
BackgroundInfluentialAhmadian, S. R., Ghasemi‐Kasman, M., Pouramir, M., & Sadeghi, F. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.11.038 · Cited by 83
Human disorders associated with inflammation and the evolving role of natural products to overcome
Kishore, N., Kumar, P., Shanker, K., & Verma, A. K. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.06.034 · Cited by 82
Jiang, Y., Gong, F.-L., Zhao, G.-B., & Li, J. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150712270 · Cited by 82
“Additionally, the therapeutic reagents that diminish either TNF-α or IL-1β production have been found in other models of neurological diseases, including ischemia, traumatic brain injury and SCI [21].”
BackgroundLevkovitz, Y., Fenchel, D., Kaplan, Z., Zohar, J., & Cohen, H. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.11.012 · Cited by 82
“As an example, TNF-α can prompt IL-1 and IL-6 activation and IL-1 in turn can induce IL-6 and TNF-α (Lucas et al., 2006).”
BackgroundThe Influence of Oxidative Stress Markers in Patients with Ischemic Stroke
Pawluk, H., Tafelska‐Kaczmarek, A., Sopońska, M., Porzych, M., Modrzejewska, M., Pawluk, M., Kurhaluk, N., Tkaczenko, H., & Kołodziejska, R. (2024) · Biomolecules · doi:10.3390/biom14091130 · Cited by 81
TNF-α and IL-8 in Acute Stroke and the Modulation of these Cytokines by Antiplatelet Agents
Al-Bahrani, A. I., Taha, S., Shaath, H., & Bakhiet, M. (2007) · Current Neurovascular Research · doi:10.2174/156720207779940716 · Cited by 81
“However, inflammatory mediators may have dual roles, with the above mentioned detrimental effects but beneficial effects in long-term repair and recovery, leading to complications in their application as novel therapies (Lucas et al., 2006).”
BackgroundCordaro, M., Impellizzeri, D., Paterniti, I., Bruschetta, G., Siracusa, R., Stefano, D. D., Cuzzocrea, S., & Esposito, E. (2014) · Journal of Neurotrauma · doi:10.1089/neu.2014.3460 · Cited by 80
Mota, B. C., Pereira, L. B., Souza, M. A., Silva, L. F. A., Magni, D. V., Ferreira, A. P. O., Oliveira, M. S., Furian, A. F., Mazzardo‐Martins, L., da Silva, M. D., et al. (2011) · Neurotoxicity Research · doi:10.1007/s12640-011-9257-8 · Cited by 82
“In fact, published data have demonstrated that TBI initiates a complex pattern of acute inflammatory events that may either aggravate outcome or reparative processes (Lucas et al. 2006).”
Prostanoid Receptor EP2 as a Therapeutic Target
Ganesh, T. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401431x · Cited by 81
“34, 36-38 Thus, in this perspective article, we focus specifically on the EP2 receptor and the binding of the natural ligand prostaglandin-E2 (PGE2)(39) (1) (Figure 4) and synthetic analogs.”
BackgroundBioactive Compounds in Ficus Fruits, Their Bioactivities, and Associated Health Benefits: A Review
Walia, A., Kumar, N., Singh, R., Kumar, H., Kumar, V., Kaushik, R., & Kumar, A. P. (2022) · Journal of Food Quality · doi:10.1155/2022/6597092 · Cited by 79
Clinical Evaluation of Lacunar Infarction and Branch Atheromatous Disease
Nakase, T., Yoshioka, S., Sasaki, M., & Suzuki, A. (2011) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2011.10.005 · Cited by 79
IL-1Ra and its Delivery Strategies: Inserting the Association in Perspective
Akash, M. S. H., Rehman, K., & Chen, S. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1118-0 · Cited by 79
Ethanol-Induced Neurodegeneration and Glial Activation in the Developing Brain
Saito, M., Chakraborty, G., Hui, M., Masiello, K., & Saito, M. (2016) · Brain Sciences · doi:10.3390/brainsci6030031 · Cited by 78
“Also, the synthesis and release of cytokines and chemokines lead to persistent migration of monocytes and neutrophils across the blood–brain barrier in some cases [75].”
BackgroundRole of Infection in the Pathogenesis of Alzheimerʼs Disease: Implications for Treatment
Holmes, C., & Cotterell, D. (2009) · CNS Drugs · doi:10.2165/11310910-000000000-00000 · Cited by 78
Davis, C. N., Tabarean, I., Gaidarova, S., Behrens, M. M., & Bartfai, T. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03951.x · Cited by 69
Ribeiro, N. A., Abreu, T. M., Chaves, H. V., Bezerra, M. M., Monteiro, H. S. A., Jorge, R. J. B., & Benevídes, N. M. B. (2014) · Inflammation Research · doi:10.1007/s00011-014-0728-2 · Cited by 77
“However, excessive or inappropriate inflammation is the cause of many diseases [6].”
BackgroundParviainen, L., Dihanich, S., Anderson, G. W., Wong, A. M., Brooks, H. R., Abeti, R., Rezaie, P., Lalli, G., Pope, S., Heales, S. J., et al. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0476-y · Cited by 71
“pathological conditions [51], therefore we compared the secretion profiles of WT and Cln3 glia under basal conditions and after stimulation.”
MethodThe Chemistry of Neurodegeneration: Kinetic Data and Their Implications
Pavlin, M., Repič, M., Vianello, R., & Mavri, J. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9284-1 · Cited by 78
Kumaran, D., Malairaman, U., Kumar, M., Aneja, R., & Katyal, A. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.06.023 · Cited by 76
Immune and Inflammatory Responses to Stroke: Good Or Bad?
McCombe, P. A., & Read, S. J. (2008) · International Journal of Stroke · doi:10.1111/j.1747-4949.2008.00222.x · Cited by 70
Harrer, C., Otto, F., Radlberger, R. F., Moser, T., Pilz, G., Wipfler, P., & Harrer, A. (2022) · Cells · doi:10.3390/cells11172649 · Cited by 76
Emergence of taurine as a therapeutic agent for neurological disorders
Jangra, A., Gola, P., Singh, J., Gond, P., Ghosh, S., Rachamalla, M., Dey, A., Iqbal, D., Kamal, M., Sachdeva, P., et al. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.374139 · Cited by 75
“(2002) found that central injection of IL-1ra showed a reduction in TBI after a certain period, between 15 and 30 minutes, and suppressed the production of IL-1 (Tehranian et al., 2002; Lucas et al., 2006).”
BackgroundInfluentialKastyak, M. Z., Nasse, M. J., Rak, M., Hirschmugl, C. J., Bigio, M. R. D., Albensi, B. C., & Gough, K. M. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.11.069 · Cited by 75
“The pathogenesis of AD remains unclear; however progress is being made in our understanding and in potential treatments to control or delay onset (Schjeide et al., 2009; Lucas et al., 2006; Mattson, 2004; Selkoe, 2004).”
BackgroundBarth, B. M., Smeets, S. S., & Kuhn, T. B. (2009) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2009.03.007 · Cited by 76
“A persistent inflammatory reaction is highly prevalent in most CNS pathologies whether acute, chronic, psychiatric, or even in normal aging with activated microglia and astrocytes releasing numerous neurotoxic mediators including cytokines and ROS (Mrak and Griffin, 2005; Lucas et al., 2006).”
BackgroundInfluentialThe Interplay of MicroRNAs in the Inflammatory Mechanisms Following Ischemic Stroke
Khoshnam, S. E., Winlow, W., & Farzaneh, M. (2017) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlx036 · Cited by 75
“Dying neurons release chemokines that guide the entry of these leukocytes (63, 64).”
BackgroundKhatri, N., Bommaraju, S., Kumar, S., Kaundal, R. K., Sharma, S., & Datusalia, A. K. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210215123914 · Cited by 74
“Similarly, extracranial injury may have a potential influence on TBI outcome as disrupted blood-brain barrier (BBB) and immune-privilege brain become vulnerable to secondary damage after TBI [19].”
BackgroundImpaired Wound Healing after Cerebral Hypoxia—Ischemia in the Diabetic Mouse
Kumari, R., Willing, L. B., Krady, J. K., Vannucci, S. J., & Simpson, I. A. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600382 · Cited by 74
“Considerable controversy surrounds the extent to which the proinflammatory responses elicited by TNFa and IL-1b play a positive or negative effect in recovery from stroke (for reviews see Lucas et al (2006), Schwartz (2003), and Streit (2002)).”
Tan, X.-X., Qiu, L.-L., & Sun, J. (2021) · BioMed Research International · doi:10.1155/2021/3883204 · Cited by 73
“In isoflurane or surgery-induced cognitive impairment models, it was found that minocycline could downregulate microglia marker IBA-1 protein expression [142] and upregulate anti-inflammatory cytokine IL-4 and IL-10 protein levels [143].”
BackgroundLiesz, A., Bauer, A. S., Hoheisel, J. D., & Veltkamp, R. C. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.07.003 · Cited by 73
Neuroprotective effect of apigenin in rats after contusive spinal cord injury
Zhang, F., Li, F., & Chen, G. (2013) · Neurological Sciences · doi:10.1007/s10072-013-1566-7 · Cited by 73
“The therapeutic values that mitigate either IL-1b or TNF-a production or signaling have been demonstrated in other models of neurological disorders, including ischemia, traumatic brain injury and SCI [18].”
BackgroundLin, H., Tang, C., Chen, J.-H., Chuang, J., Huang, S.-M., Tan, T., Lai, C., & Lu, D. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22489 · Cited by 73
“On the other hand, IL-6 has also been reported to be a potential inflammatory cytokine in various central nervous system diseases (Loddick et al., 1998; Ali et al., 2000; Samland et al., 2003; Lucas et al., 2006; Ohtaki et al., 2006; Westberg et al., 2007).”
BackgroundPengyue, Z., Guo, T., He, H., Liqiang, Y., & Yihao, D. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.03.039 · Cited by 73
The role of inflammation and interleukin-1 in acute cerebrovascular disease
Brough, D., & Galea, J. (2013) · Journal of Inflammation Research · doi:10.2147/jir.s35629 · Cited by 62
“Cytokines of the IL-1 family, namely the IL-1α and IL-1β isoforms, are strongly implicated in sterile inflammatory responses that worsen acute cerebrovascular disease.(4)”
BackgroundThe antinociceptive and anti-inflammatory activities of Piptadenia stipulacea Benth. (Fabaceae)
de Queiroz, A. C., de Lira, D. P., Dias, T. D. L. M. F., de Souza, É. T., da Matta, C. B. B., de Aquino, A. B., Silva, L. H. A. C., da Silva, D. J. C., Mella, E. A. C., Agra, M. D. F., et al. (2010) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2010.01.041 · Cited by 72
Kovács, Z., Czurkó, A., Kékesi, K. A., & Juhász, G. D. (2011) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.05.003 · Cited by 72
New roles of reactive astrocytes in the brain; an organizer of cerebral ischemia
Koizumi, S., Hirayama, Y., & Morizawa, Y. M. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.01.007 · Cited by 72
Mechanisms of regulation for interleukin-1β in neurodegenerative disease
Simi, A., Lerouet, D., Pinteaux, E., & Brough, D. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.02.011 · Cited by 72
Gnatek, Y., Zimmerman, G., Goll, Y., Najami, N., Soreq, H., & Friedman, A. (2012) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2012.00066 · Cited by 73
“We hypothesized that the injury associated with the slicing procedure would activate a significant inflammatory response (Lucas et al., 2006) which could be suppressed by cholinergic stimuli.”
BackgroundGreen, T. R. F., Ortiz, J. B., Wonnacott, S., Williams, R. J., & Rowe, R. K. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00894 · Cited by 71
Ahmed, F. A. K. M., Plantman, S., Černak, I., & Agoston, D. V. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00114 · Cited by 71
“Inflammation can also be triggered by injury-induced changes in cellular adhesion (72, 73).”
BackgroundCai, J., Jing, D., Shi, M., Liu, Y., Lin, T., Xie, Z., Zhu, Y., Zhao, H., Shi, X., Du, F., et al. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.02.012 · Cited by 71
“Inflammatory responses play a crucial role in the CNS damage and are regarded as an early phenomenon in the CNS damage process [33].”
BackgroundChen, S., Wu, H., Klebe, D. W., Hong, Y., & Zhang, J. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1241-2 · Cited by 71
“Neuroinflammation is an essential element in the pathogenesis of CNS disorders and a major contributor to brain damage [47, 48].”
Metallothionein and brain inflammation
Manso, Y., Adlard, P. A., Carrasco, J., Vašák, M., & Hidalgo, J. (2011) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-011-0802-y · Cited by 69
“significantly to the neuropathology of several adult neurodegenerative disorders as well as stroke, trauma, seizures, and neuronal degeneration, and that cytokines play a prominent role (Frei et al., 1988; Hopkins and Rothwell, 1995; Rothwell and Hopkins, 1995; Gruol and Nelson, 1997; Muñoz-Fernández and Fresno, 1998;…”
BackgroundRegulation of Kir4.1 expression in astrocytes and astrocytic tumors: a role for interleukin-1 β
Zurolo, E., de Groot, M., Iyer, A. M., Anink, J. J., van Vliet, E. A., Heimans, J. J., Reijneveld, J. C., Gorter, J. A., & Aronica, E. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-280 · Cited by 70
“IL-1Ra is a naturally occurring antagonist of the IL-1 receptor [38], which is also regulated in response to different forms of CNS insult (for review see [1,22,50]).”
BackgroundThe Role of Eicosanoids in Alzheimer’s Disease
Biringer, R. G. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16142560 · Cited by 64
Xu, L. B., Yue, J. K., Korley, F. K., Puccio, A. M., Yuh, E. L., Sun, X., Rabinowitz, M., Vassar, M. J., Taylor, S. R., Winkler, E. A., et al. (2020) · Journal of Neurotrauma · doi:10.1089/neu.2020.7177 · Cited by 70
“allows peripheral inflammatory factors to access the brain tissue, leading to activation of neuroinflammatory cascades.(40) It is rea-”
BackgroundChemokine detection in the cerebral tissue of patients with posttraumatic brain contusions
Stefini, R., Catenacci, E., Piva, S., Sozzani, S., Valerio, A., Bergomi, R., Cenzato, M., Mortini, P., & Latronico, N. (2008) · Journal of Neurosurgery · doi:10.3171/jns/2008/108/5/0958 · Cited by 65
Biancotti, J. C., Kumar, S., & de Vellis, J. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9792-8 · Cited by 69
“In addition, during inflammation, pro-inflammatory cytokines play an essential role through the induction of chemokines and adhesion molecules, recruitment and activation of immune cells and endogenous glial cells [ 33 ].”
BackgroundYan, J., Kothur, K., Mohammad, S. S., Chung, J., Patel, S., Jones, H. F., Keating, B. A., Han, V. X., Webster, R., Ardern‐Holmes, S. L., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104589 · Cited by 69
Xu, H., Qin, W., Xiao, H., Mu, S., Zhu, J., Lu, W., & Luo, Y. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1117-5 · Cited by 69
Friend, S. F., Nachnani, R., Powell, S. B., & Risbrough, V. B. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.15031 · Cited by 69
“In both the periphery and CNS, this cascade triggers C3 convertase and later C5 convertase as part of the terminal pathway to ultimately form the Membrane Attack Complex (MAC; Lucas et al., 2006; Merle et al., 2015).”
BackgroundMukhara, D., Oh, U., & Neigh, G. N. (2020) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64123-6.00017-5 · Cited by 70
In SituDeposition of Complement in Human Acute Brain Ischaemia
Pedersen, E. D., Løberg, E. M., Vege, E., Daha, M. R., Mæhlen, J., & Mollnes, T. E. (2009) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2009.02253.x · Cited by 69
Neuroinflammation in Alzheimer's disease: protector or promoter?
Žilka, N., Ferencĭk, M., & Hulín, I. (2006) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/bf03656856 · Cited by 69
Recent biological applications of heterocyclic hybrids containing s -triazine scaffold
Ali, M. I., & Naseer, M. M. (2023) · RSC Advances · doi:10.1039/d3ra05953g · Cited by 68
Li, J., Zhang, S., Lu, M., Chen, Z., Chen, C., Han, L., Zhang, M., & Xu, Y. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2012.12.056 · Cited by 68
A new role for interferon gamma in neural stem/precursor cell dysregulation
Walter, J., Honsek, S. D., Illes, S., Wellen, J. M., Hartung, H.-P., Rose, C. R., & Dihné, M. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-18 · Cited by 59
“As nearly all CNS diseases involve acute and chronic inflammatory processes [2], it is crucial to understand NSPC development under inflammatory conditions to better realize their full potential.”
BackgroundLipocalin-2 Acts as a Neuroinflammatogen in Lipopolysaccharide-injected Mice
Jin, M., Jang, E., & Suk, K. (2014) · Experimental Neurobiology · doi:10.5607/en.2014.23.2.155 · Cited by 65
“There is much evidence that inflammation and inflammatory mediators contribute to the pathogenesis of CNS injuries and neurological diseases [2], including stroke [3], traumatic brain injury [4], Alzheimer’s disease [5], Parkinson’s disease [6, 7], and multiple sclerosis [8].”
BackgroundDeng, Y., Chen, D., Wang, L., Gao, F., Jin, B., Lv, H., Zhang, G., Sun, X., Liu, L., Mo, D., et al. (2019) · Stroke · doi:10.1161/strokeaha.118.023376 · Cited by 67
“Microglial cells, which are rapidly and time dependently activated after ischemia, are considered as the major cellular contributors to neuroinflammation in ischemic stroke,(5) and cytokines such as TNF-α (tumor necrosis factor-α), IL (interleukin)-1β, IL-6, and reactive oxygen species produced by microglial cells hav…”
BackgroundTrendelenburg, G. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600609 · Cited by 64
Fontenelle, T. P. C., Lima, G. C., Mesquita, J. X., Lopes, J. L. D. S., de Brito, T. V., Júnior, F. D. C. V., Sales, A. B., Aragão, K. S., de Souza, M. H. L. P., Barbosa, A. L. D. R., et al. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.02.058 · Cited by 67
Inflammation in neurological and psychiatric diseases
Khansari, P. S., & Sperlágh, B. (2012) · Inflammopharmacology · doi:10.1007/s10787-012-0124-x · Cited by 66
Scherer, E. B. S., Loureiro, S. O., Vuaden, F. C., da Cunha, A. A., Schmitz, F., Kolling, J., Savio, L. E. B., Bogo, M. R., Bonan, C. D., Netto, C. A., et al. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8660-6 · Cited by 68
“TNF-α is the key initiator of immune-mediated inflammation in multiple organ systems including the brain [40], acting synergistically with IL-1β to induce IL-6 expression [41].”
Inflammation in adult and neonatal stroke
Vexler, Z. S., Tang, X. N., & Yenari, M. A. (2006) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2006.09.008 · Cited by 66
“Many factors affect BBB breakdown [11,133].”
Campbell, S. J., Deacon, R. M. J., Jiang, Y., Ferrari, C., Pitossi, F. J., & Anthony, D. C. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.04.013 · Cited by 60
“Interleukin-1 (IL-1β) contributes to a broad spectrum of central nervous system (CNS) pathologies, where it is known to modify behaviour and exacerbate neuronal loss (for a review, see Lucas et al., 2006) via IL-1 receptors present on neurons, glia and endothelial cells.”
InfluentialKharatishvili, I., Shan, Z., She, D. T., Foong, S., Kurniawan, N. D., & Reutens, D. C. (2013) · Brain Structure and Function · doi:10.1007/s00429-013-0528-4 · Cited by 65
“Activation of the complement system is an important component of the inflammatory response, leading to activation of microglia, secretion of proinflammatory cytokines, recruitment of macrophages, activation of phagocytosis and increased vascular permeability (Lucas et al. 2006).”
Barth, B. M., Gustafson, S. J., & Kuhn, T. B. (2012) · Journal of Neuroscience Research · doi:10.1002/jnr.22748 · Cited by 51
“…sphingomyelinase; ceramide; NADPH oxidase; sphingosine kinase; neuroinflammation A progressively spreading inflammation and oxidative stress are hallmarks of many chronic central nervous system (CNS) diseases, acute CNS injuries, some psychi- atric disorders, and aging CNS (Lucas et al., 2006).”
BackgroundInfluentialKohsaka, S., Volcik, K. A., Folsom, A. R., Wu, K. K., Ballantyne, C. M., Willerson, J. T., & Boerwinkle, E. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.02.010 · Cited by 65
Time course Analysis of Gene expression patterns in ZebrafIsh Eye during Optic Nerve Regeneration
McCurley, A., & Callard, G. V. (2010) · Journal of Experimental Neuroscience · doi:10.4137/jen.s5006 · Cited by 65
Reactive and Senescent Astroglial Phenotypes as Hallmarks of Brain Pathologies
Lazic, A., Balint, V., Ninković, D. S., Perić, M., & Stevanović, M. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094995 · Cited by 65
Rao, A. M., & Hatcher, J. F. (2007) · Brain Research · doi:10.1016/j.brainres.2006.11.080 · Cited by 64
“In contrast, exogenous administration of IL-6 to the brain was found to attenuate stroke injury ( Lucas et al., 2006 ).”
BackgroundRetractedAge-dependent response of CCAAT/enhancer binding proteins following traumatic brain injury in mice
Sandhir, R., & Berman, N. E. J. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2009.10.002 · Cited by 56
“Neuroinflammation contributes to the pathophysiology of brain trauma (Lucas et al., 2006; Morganti-Kossmann et al., 2002; Tansey et al., 2009).”
BackgroundMembrane attack complex inhibitor CD59a protects against focal cerebral ischemia in mice
Harhausen, D., Khojasteh, U., Stahel, P. F., Morgan, B. P., Nietfeld, W., Dirnagl, U., & Trendelenburg, G. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-15 · Cited by 64
“The complement system has been recently identified as a conductor of inflammation triggering further tissue damage in experimental ischemia [31].”
BackgroundMitochondrial Transfer as a Therapeutic Strategy Against Ischemic Stroke
Chen, W., Huang, J., Hu, Y., Khoshnam, S. E., & Sarkaki, A. (2020) · Translational Stroke Research · doi:10.1007/s12975-020-00828-7 · Cited by 66
“Following ischemic stroke, microglia are the first brainintrinsic immune cells activated which is followed by BBB disruption and infiltration of systemic immune cells (especially neutrophils and monocytes/macrophages) into the brain tissue [43, 44].”
BackgroundIL-6 polymorphism associated with fatal outcome in patients with severe traumatic brain injury
Libera, A. L. D., Regner, A., de Paoli, J., Centenaro, L., Martins, T. T., & Simon, D. (2011) · Brain Injury · doi:10.3109/02699052.2011.556107 · Cited by 63
“acterized by activation of microglia and astrocytes, damage to the blood–brain barrier and production of cytokines [2, 3].”
BackgroundAndrogens modulate chronic intermittent hypoxia effects on brain and behavior
Snyder, B., Duong, P., Trieu, J., & Cunningham, R. L. (2018) · Hormones and Behavior · doi:10.1016/j.yhbeh.2018.09.005 · Cited by 63
“The cyclic relationship between oxidative stress and inflammation may partially explain why both elevated oxidative stress and inflammation are reported to contribute to neurodegenerative diseases (Barnham et al., 2004; Chao et al., 2014; Jenner, 2003; Lucas et al., 2006).”
Maldonado, J., Huang, J. H., Childs, E. W., & Tharakan, B. (2022) · Journal of Neurotrauma · doi:10.1089/neu.2021.0455 · Cited by 63
Lim, S.-W., Wang, C.-C., Wang, Y.-H., Chio, C., Niu, K., & Kuo, J. (2013) · Journal of Surgical Research · doi:10.1016/j.jss.2013.04.070 · Cited by 63
Expression, transport, and axonal sorting of neuronal CCL21 in large dense‐core vesicles
de Jong, E. K., Vinet, J., Stanulovic, V. S., Meijer, M., Wesseling, E., Sjollema, K., Boddeke, H. W. G. M., & Biber, K. (2008) · The FASEB Journal · doi:10.1096/fj.07-101907 · Cited by 59
Molecular targets for axon regeneration: focus on the intrinsic pathways
Giovanni, S. D. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903307517 · Cited by 63
“Inflammationmediated by macrophages that invade the lesion site through breakage of the blood–brain barrier and by resident microglia is responsible for the majority of the acute and sub-acute cytotoxic phenomena [3-5].”
BackgroundAnti-Inflammatory and Analgesic Activities of a Novel Biflavonoid from Shells of Camellia oleifera
Ye, Y., Guo, Y., & Luo, Y. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131012401 · Cited by 63
“Inflammation as one major cause of pain is related to cancer, diabetes and cardiovascular disease [3].”
WWOX Loss of Function in Neurodevelopmental and Neurodegenerative Disorders
Aldaz, C. M., & Hussain, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238922 · Cited by 62
“Clinical and experimental observations have provided strong evidence that inflammation may constitute a crucial mechanism in the pathophysiology of CNS disorders [37].”
BackgroundCawthorne, C., Prenant, C., Smigova, A., Julyan, P., Maroy, R., Herholz, K., Rothwell, N., & Boutin, H. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01068.x · Cited by 54
“Both experimental models and clinical studies suggest that IL-1 receptor agonists and their pro-inflammatory actions are detrimental in such neuropathological conditions, whereas IL-1 antagonism seems beneficial (see Allan, et al., 2005 and Lucas et al., 2006).”
BackgroundSelf-citationHakan, T., Toklu, H. Z., Biber, N., Özevren, H., Solakoğlu, S., Demırtürk, P., & Aker, F. (2009) · Neurological Research · doi:10.1179/016164109x12464612122731 · Cited by 62
Neuroinflammation induces glial aromatase expression in the uninjured songbird brain
Duncan, K. A., & Saldanha, C. J. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-81 · Cited by 59
“Their presence following injury has implicated them as mediators and inhibitors of neurodegeneration [17,19,23-26].”
BackgroundBeynon, A. L., & Coogan, A. N. (2010) · Chronobiology International · doi:10.3109/07420528.2010.501927 · Cited by 52
“A cytokine of major importance, playing many roles in the inflammatory response and in the central nervous system, which has not been well investigated in relation to the circadian clock, is interleukin-1β (IL-1β) (Lucas et al., 2006).”
BackgroundDietary Regulation of Gut-Brain Axis in Alzheimer’s Disease: Importance of Microbiota Metabolites
Frausto, D. M., Forsyth, C. B., Keshavarzian, A., & Voigt, R. M. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.736814 · Cited by 61
Mesenchymal Stem Cells: Therapeutic Mechanisms for Stroke
Zhang, Y., Dong, N., Hong, H., Qi, J., Zhang, S., & Wang, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052550 · Cited by 61
“Subsequently, both the secretion of TNF-α in dendritic cells and the secretion of IFN-γ in T helper 1 and natural killer (NK) cells decreased [36,37].”
BackgroundVery early-initiated physical rehabilitation protects against ischemic brain injury
Hu, Y. (2012) · Frontiers in Bioscience · doi:10.2741/e559 · Cited by 57
Matousek, S. B., Hein, A. M., Shaftel, S. S., Olschowka, J. A., Kyrkanides, S., & O’Banion, M. K. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06759.x · Cited by 55
“Research suggests that an inappropriate or prolonged neuroinflammatory response can exacerbate injury or disease in the surrounding tissue (Lucas et al. 2006).”
BackgroundBuffolo, F., Petrosino, V., Albini, M., Moschetta, M., Carlini, F., Floss, T., Kerlero de Rosbo, N., Cesca, F., Rocchi, A., Uccelli, A., et al. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-03465-6 · Cited by 60
Stimulation of prostaglandin E2-EP3 receptors exacerbates stroke and excitotoxic injury
Ahmad, M., Ahmad, A. S., ZHUANG, H., Maruyama, T., Narumiya, S., & Doré, S. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.12.012 · Cited by 60
“Inflammation has been shown to play a major role in the pathological response and outcome of stroke and other central nervous system disorders (Huang et al., 2006;Lucas et al., 2006).”
BackgroundThe Analgesic, Anti-Inflammatory and Anti-Pyretic Activities of Tinospora cordifolia
Hussain, L., Akash, M. S. H., Ain, N., Rehman, K., & Ibrahim, M. (2015) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/27909 · Cited by 60
“immune diseases [34–42].”
García-Álvarez, L., Caso, J. R., García‐Portilla, M. P., de la Fuente-Tomás, L., González-Blanco, L., Sáiz, P. A., Leza, J. C., & Bobes, J. (2017) · European Psychiatry · doi:10.1016/j.eurpsy.2017.09.007 · Cited by 60
Wu, J., Ding, D., Li, Q., Wang, X.-Y., Sun, Y., & Li, L.-J. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00019 · Cited by 60
In vivo characterization of functional states of cortical microglia during peripheral inflammation
Riester, K., Brawek, B., Savitska, D., Fröhlich, N., Zirdum, E., Mojtahedi, N., Heneka, M. T., & Garaschuk, O. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.12.007 · Cited by 58
Candore, G., Balistreri, C. R., Grimaldi, M. P., Vasto, S., Listì, F., Chiappelli, M., Licastro, F., Lio, D., & Caruso, C. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1386.008 · Cited by 60
Metadata
- Authors
- Lucas, S., Rothwell, N. J., & Gibson, R. M.
- Affiliations
- University of Manchester (GB)
- HSE Science and Research Centre (GB)
- Corresponding author
- Rothwell, Nancy J
- ORCID
- Rothwell, Nancy J
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2006-01
- Volume
- 147
- Issue
- S1
- Pages
- S232-40
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- PMC
- PMC1760754
- OpenAlex
- W1594425991
- Cited by
- 1,272
- References
- 41
- Citations by year
- 2026: 12 · 2025: 37 · 2024: 32 · 2023: 57 · 2022: 65 · 2021: 69 · 2020: 62 · 2019: 80 · 2018: 67 · 2017: 67 · 2016: 60 · 2015: 89 · 2014: 77 · 2013: 79 · 2012: 62
- FWCI
- 7.38
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- British Journal of Pharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
- Keywords
- neuroinflammation, central nervous system injury, immune privilege, inflammatory cytokines, prostaglandins, free radicals, complement system, chemokines, glial activation, interleukin-1, interleukin-1 receptor antagonist, stroke, traumatic brain injury, Alzheimer's disease, anti-inflammatory therapy, neurodegeneration, aging
- MeSH terms
- Acute Disease, Animals, Brain, Central Nervous System Diseases, Chronic Disease, Craniocerebral Trauma, Humans, Inflammation, Inflammation Mediators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.